Cargando…
BRCA1 mutations in southern England.
If genetic testing for breast and ovarian cancer predisposition is to become available within a public health care system there needs to be a rational and cost-effective approach to mutation analysis. We have screened for BRCA1 mutations in 230 women with breast cancer, all from the Wessex region of...
Autores principales: | Eccles, D. M., Englefield, P., Soulby, M. A., Campbell, I. G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150412/ https://www.ncbi.nlm.nih.gov/pubmed/9649133 |
Ejemplares similares
-
BRCA1 polymorphisms.
por: Campbell, I. G., et al.
Publicado: (1997) -
No association of a 306-bp insertion polymorphism in the progesterone receptor gene with ovarian and breast cancer.
por: Manolitsas, T. P., et al.
Publicado: (1997) -
BRCA1 and BRCA2 mutations in central and southern
Italian patients
por: Ottini, Laura, et al.
Publicado: (2000) -
Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland
por: Wojcik, P., et al.
Publicado: (2016) -
Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12.
por: Englefield, P., et al.
Publicado: (1994)